PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070378
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070378
The global disposable endoscopes market was valued at USD 3.10 billion in 2025 and is projected to grow from USD 3.53 billion in 2026 to USD 10.30 billion by 2034, registering a CAGR of 14.3% during the forecast period. Disposable endoscopes are single-use, minimally invasive medical devices used for diagnostic and therapeutic procedures in gastroenterology, pulmonology, urology, ENT, orthopedics, and other clinical areas.
The market is growing due to rising concerns over Hospital-Acquired Infections, strict infection-control guidelines, and increasing preference for sterile single-use devices. These endoscopes eliminate the need for reprocessing and reduce cross-contamination risks. North America dominated the global market in 2025 with a 38.38% market share.
Market Trends
A major market trend is the rapid technological advancement in disposable endoscopes. Companies are improving image quality, device maneuverability, working channels, digital connectivity, and sensor integration. These improvements are narrowing the performance gap between reusable and disposable scopes.
In May 2024, Ambu's aScope Gastro Large received FDA clearance with an improved working channel, supporting better clinical performance in therapeutic procedures.
Market Drivers
Rising infection-control concerns are a key driver of market growth. Reusable endoscopes require complex cleaning and reprocessing, yet contamination risks may still remain. Disposable endoscopes provide a sterile device for every procedure, improving patient safety and reducing infection risks. Regulatory support and hospital safety protocols are further encouraging adoption.
Market Restraints
High procedural cost is a major restraint. Disposable endoscopes require continuous procurement for every procedure, increasing operating expenses for hospitals and clinics. In comparison, reusable endoscopes involve high upfront cost but can be used repeatedly. Budget constraints and reimbursement challenges, especially in emerging countries, may restrict adoption.
Market Opportunities
Rising healthcare investments in emerging markets offer strong opportunities. Asia Pacific and Latin America are witnessing improvements in healthcare infrastructure, growing awareness of infection control, and rising demand for minimally invasive procedures. Increasing cases of gastrointestinal and respiratory disorders are also supporting demand for single-use endoscopes.
In January 2021, AIG Hospitals in India began using disposable duodenoscopes, marking an important step for adoption in Asia.
Market Challenges
Shortage of skilled professionals in emerging countries remains a challenge. Although disposable devices reduce infection risk, procedures still require trained endoscopists and support staff. Limited training programs and lack of technical expertise can affect procedural efficiency and slow adoption of advanced endoscopic technologies.
Segment Analysis
By product, the market is segmented into bronchoscopes, gastrointestinal endoscopes, ureteroscopes, and others. The gastrointestinal endoscope segment held the largest market share in 2025 due to the high volume of colonoscopy and gastroscopy procedures worldwide. The bronchoscope segment is projected to grow at a CAGR of 13.8% during the forecast period.
By application, the market is classified into gastroenterology, pulmonology, urology, orthopedics, and others. The gastroenterology segment dominated in 2025 due to the rising burden of digestive diseases and frequent use of endoscopy for diagnosis and treatment. The segment is expected to hold 35.1% share in 2026. The pulmonology segment is projected to grow at a CAGR of 13.5%.
By end user, the market includes hospitals & ASCs, specialty clinics, and others. Hospitals & ASCs dominated in 2025 due to high procedural volumes, strong infection-control focus, and preference for patient safety. This segment is expected to hold 70.5% share in 2026. Specialty clinics are projected to grow at a CAGR of 15.4%.
Regional Analysis
North America led the global market with USD 1.19 billion in 2025, increasing from USD 1.04 billion in 2024. The U.S. market is expected to reach USD 1.18 billion in 2026, accounting for approximately 33.4% of global revenue.
Asia Pacific is projected to reach USD 0.66 billion in 2026, becoming the second-largest regional market. China is expected to reach USD 0.28 billion, Japan USD 0.14 billion, and India USD 0.11 billion in 2026.
Europe is projected to reach USD 1.04 billion in 2026, growing at a 13.3% rate during the forecast period. The U.K. market is expected to reach USD 0.19 billion, while Germany is projected at USD 0.25 billion in 2026.
Latin America is estimated to reach USD 0.23 billion in 2026, supported by healthcare infrastructure improvements and rising adoption of advanced medical technologies. The GCC market is projected to reach USD 0.07 billion in 2026.
Competitive Landscape
The market is competitive, with leading companies focusing on product expansion, FDA clearances, innovation, digital imaging, and strategic partnerships. Key players include Boston Scientific Corporation, PENTAX Medical, Ambu A/S, Integrated Endoscopy, UroViu Corporation, CooperSurgical, Flexicare, Welch Allyn/Baxter, Olympus Corporation, and OTU Medical. Boston Scientific, Olympus, and Ambu held the highest market share in 2025 due to their broad single-use endoscope portfolios.
Key Industry Developments
In May 2025, Olympus received FDA 510(k) clearance for its EZ1500 series endoscopes. In July 2024, Ambu received FDA clearance for aScope 5 Uretero. In April 2024, Olympus launched Vathin E-SteriScope in the U.S. for ENT procedures. In April 2024, Ambu received FDA clearance for aScope Gastro Large. In September 2021, Boston Scientific launched EXALT Model D Duodenoscope and EXALT Model B Bronchoscope.
Conclusion
The disposable endoscopes market is expected to grow from USD 3.10 billion in 2025 to USD 3.53 billion in 2026, reaching USD 10.30 billion by 2034. Growth will be driven by infection-control concerns, minimally invasive procedure demand, regulatory support, and technology improvements. However, high per-procedure costs and skilled workforce shortages may challenge wider adoption.
Segmentation By Product, Application, End-user, and Region
By Product * Bronchoscope
By Application * Gastroenterology
By End-user * Hospitals & ASCs
By Region * North America (By Product, Application, End-user, and Country)